- Fund Type: SICAV
- Objective: Growth
- Asset Class: Equity
- Geographic Focus: Spain
Valor Creixent SICAV SA
+ Add to WatchlistS2958:SM
1.14 EUR 0.000.00%As of 10:00:53 ET on 05/23/2013.
Snapshot for Valor Creixent SICAV SA (S2958)
| Year To Date: | +4.68% | 3-Month: | +3.98% | 3-Year: | +3.74% | 52-Week Range: | 1.01 - 1.14 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +2.28% | 1-Year: | +11.75% | 5-Year: | +0.06% | Beta vs IBEX: | 0.46 |
Fund Profile & Information for S2958
Valor Creixent SICAV SA is an open-end investment company incorporated in Spain. The investment company's objective is capital growth. It primarily invests in quity securities.
| Inception Date: | 01-12-2007 | Telephone: | 34-90-211-2211 Tel |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.santanderga.es | ||
Fundamentals for S2958
| NAV | (on 2013-05-23) 1.14 |
|---|---|
| Assets (M) | (on 2013-04-04) 2.50 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for S2958
No dividends reported
Fees & Expenses for S2958
| Front Load | - |
|---|---|
| Back Load | - |
| Current Mgmt Fee | 0.60 |
| Redemption Fee | - |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for S2958
Filing Date: 09/30/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| SGLT 0 09/20/13 | 525 | 504,787 | 19.172% |
| PIMCO Funds Global Investors S | 27,438 | 423,093 | 16.070% |
| M&G Optimal Income Fund | 26,224 | 421,297 | 16.001% |
| ICO 4 ⅜ 03/31/14 | 200 | 202,366 | 7.686% |
| TELEFO 5.431 02/03/14 | 100 | 106,492 | 4.045% |
| FADE 5 06/17/15 | 100 | 102,120 | 3.879% |
| SANTAN 4 ¼ 04/07/14 | 100 | 101,731 | 3.864% |
| POPSM 4 ⅝ 04/19/13 | 100 | 99,722 | 3.788% |
| SABSM 4 ¼ 03/29/13 | 100 | 99,710 | 3.787% |
| BBVASM 3 ¼ 04/23/15 | 100 | 97,826 | 3.716% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page